Clinical Scorecard: Factors Influencing Clostridium difficile Infection Risk Following Stoma Reversal in Patients Undergoing TaTME Surgery
At a Glance
Category
Detail
Condition
Clostridium difficile Infection (CDI) after stoma reversal
Key Mechanisms
Colonization of gastrointestinal tract by C. difficile spores and toxins leading to diarrhea and pseudomembranous colitis
Target Population
Patients undergoing stoma reversal after Transanal Total Mesorectal Excision (TaTME) for rectal cancer
Care Setting
Surgical and postoperative care in tertiary hospital setting
Key Highlights
CDI incidence is higher after colon surgery (2.2%) and even higher (4%) after stoma reversal compared to general population (1%).
Risk factors for CDI include old age, prolonged hospitalization, antibiotic use, proton pump inhibitors, and immunosuppression.
Diagnosis requires watery diarrhea plus positive stool toxin tests or endoscopic/histologic evidence; diarrhea post-stoma reversal may be confounded by diversion colitis.
Guideline-Based Recommendations
Diagnosis
Test stool samples for C. difficile toxin A/B and glutamate dehydrogenase antigen (GDH) in patients with >10 diarrhea stools/day post-stoma reversal.
Confirm CDI if both GDH and toxin A/B are positive; if GDH positive but toxin negative, perform nucleic acid amplification test.
Management
Administer single-dose Cefazoline prophylaxis at stoma reversal surgery.
Monitor and manage CDI according to clinical presentation and test results.
Monitoring & Follow-up
Monitor patients post-stoma reversal for diarrhea frequency and signs of infection.
Use stool testing protocols for early detection of CDI in symptomatic patients.
Risks
Increased CDI risk with older age, prolonged hospitalization, antibiotic and proton pump inhibitor use, immunosuppression, and neoadjuvant/adjuvant therapies.
Potential diagnostic confusion due to diversion colitis causing diarrhea.
Patient & Prescribing Data
Patients undergoing stoma reversal after TaTME surgery for rectal cancer
Prophylactic single-dose Cefazoline is standard; antibiotic stewardship and monitoring for CDI symptoms are critical postoperatively.
Clinical Best Practices
Perform multidisciplinary evaluation preoperatively to assess risk factors influencing CDI.
Standardize surgical technique and postoperative care including stoma reversal timing and integrity testing.
Implement stool testing protocols for patients with significant diarrhea post-stoma reversal to promptly diagnose CDI.
Use supervised machine learning models to identify patients at higher risk for CDI and tailor monitoring accordingly.
Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.
